
Thursday, December 27, 2007 |
|
|
An international website dedicated to providing current information on news, reports, publications,and peer-reviewed research articles concerning alcoholism and alcohol-related problems throughout the world. Postings are provided by international contributors who monitor news, publications and research findings in their country, geographical region or program area of interest. All postings are entered without editorial or contributor opinion or comment.

Thursday, December 27, 2007 |
|
|
Action News Vol. XVII No. 4 (2007)
Contents:
* IOS beats predictions: Attendance at CCSA's biennial conference approaches 1,000
* Youth Drug Prevention Strategy: CCSA's new five-year plan will target Canada's 10-24 year olds
* Driving after drinking persists: CCSA bases journal article on 2004 CAS drinking-driving data
* Tungasuvvingat Inuit partnership a first: CCSA signs its first Inuit-specific memorandum of agreement
* Centre Dollard-Cormier makes history: Quebec designates its first University Institute in Addictions
* New electronic newsletter launched: Network News targets Canada's substance abuse workforce
* Women's issues explored at IOS: CCSA and BCCEWH sponsor national networking session
Download Full Publication (PDF)
______________________________________________________________________________

| January 2008 | vol. 9 issue 1 |
Center Line Newsletter
The Impact of Depressive Symptoms on Alcohol and Cigarette Consumption Following Treatment for Alcohol and Nicotine Dependence Depressive symptoms were prospectively related to nonabstinence from alcohol. Depressive symptoms at the previous assessment increased the odds of drinking at the subsequent time point by a factor of 1.67 (95% CI 1.14, 2.43), p <>
Depression is an important negative predictor of the ability to maintain abstinence from alcohol within the context of intensive alcoholism and smoking treatment. It may be important to include depression-specific interventions for alcohol and tobacco dependent individuals to facilitate successful drinking treatment outcomes.
Request Reprint E-Mail: Molly.Kodl@va.gov
_______________________________________________________________
Traffic Safety and Alcohol Regulation: A Symposium
Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2006
Prime Minister takes charge of battle against binge-drinkingAs Britain recovers from an epic seasonal party spree, a radical package of measures to create a "cultural shift" away from the epidemic of binge drinking is being drawn up by Gordon Brown.
Parents will be encouraged to educate their children in the dangers of drink under proposals discussed at a Downing Street summit. Ministers are also contemplating moves to raise the tax on the most potent beers and mixers associated with binge drinking by putting duty on units of alcohol. Mr Brown is also being urged by Labour MPs to force supermarkets to raise the minimum price of drink to reduce the attraction of cheap alcohol.
. . . . . .
________________________________________________________________
Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and womenParallel nested case-control studies among women [Nurses’ Health Study (NHS)] and men [Health Professionals Follow-up Study (HPFS)] where 246 women and 259 men who developed incident CHD were matched to controls (1:2) on age and smoking.
The TaqIB variant and alcohol consumption were associated with higher HDL-C, with the most pronounced effects of alcohol among B2 carriers. In the NHS we did not find an inverse association between alcohol and CHD in B2 non-carriers (P trend: 0.5), but did among B2 carriers (P trend <0.01).
Among non-carriers the odds ratio (OR) for CHD among women with an intake of 5–14 g/day was 1.4 (95% CI: 0.6–3.7) compared with non-drinkers, whereas among B2 carriers the OR was 0.4 (0.2–0.8). Results in men were less suggestive of an interaction; corresponding OR’s were 1.9 (0.8–4.5) and 0.9 (0.5–1.6), for B2 non-carriers and carriers, respectively.
The association of alcohol with HDL-C levels was modified by CETP TaqIB2 carrier status, and there was also a suggestion of a gene–environment interaction on the risk of CHD.
Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP studyTo investigate the prognostic importance of drinking habits among patients surviving a first AMI.
We recorded 267 deaths, and 145 deaths from cardiac causes, during the follow-up period. After adjustment for several potential confounders, hazard ratios for total and cardiac mortality were 0.77 and 0.61 for those drinking >0–<5> those drinking over 20 g per day.
A Systematic Single Nucleotide Polymorphism Screen to Fine-Map Alcohol Dependence Genes on Chromosome 7 Identifies Association With a Novel Susceptibility Gene ACN9Chromosome 7 has shown consistent evidence of linkage with a variety of phenotypes related to alcohol dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) project.
With a sample of 262 densely affected families, a peak logarithm of odds (LOD) score for alcohol dependence of 2.9 was observed at D7S1799. The LOD score in the region increased to 4.1 when a subset of the sample was genotyped with the Illumina Linkage III panel for the Genetic Analysis Workshop 14 (GAW14).
To follow up on this linkage region, we systematically screened single nucleotide polymorphisms (SNPs) across a 2 LOD support interval surrounding the alcohol dependence peak.
The SNPs were selected from the HapMap Phase I CEPH data to tag linkage disequilibrium bins across the region. Across the 18-Mb region, genotyped by the Center for Inherited Disease Research (CIDR), 1340 SNPs were analyzed. Family-based association analyses were performed on a sample of 1172 individuals from 217 Caucasian families.
Eight SNPs showed association with alcohol dependence at p < .01. Four of the eight most significant SNPs were located in or very near the ACN9 gene. We conducted additional genotyping across ACN9 and identified multiple variants with significant evidence of association with alcohol dependence.
These analyses suggest that ACN9 is involved in the predisposition to alcohol dependence. Data from yeast suggest that ACN9 is involved in gluconeogenesis and the assimilation of ethanol or acetate into carbohydrate.
Request Reprint E-Mail: ddick@vcu.edu
Fetal Alcohol Syndrome Prevention Using Community-Based Narrowcasting CampaignsPreventing fetal alcohol syndrome (FAS) by encouraging pregnant women to abstain from drinking alcohol competes with commercial alcohol marketing.
Two FAS-prevention campaigns using a narrowcast approach among young women of childbearing age in two disadvantaged Southern California communities are compared. The design, implementation process, and degree to which campaigns reached the priority populations are the focus of this article.
Formative research shows that young women in disadvantaged communities receive mixed messages about dangers of drinking during pregnancy. A social norms approach using positive role models was the most acceptable message strategy based on materials pretesting.
Differences in campaign implementation and distribution strategies between communities were documented through program monitoring. Survey research indicated the more viable messaging and implementation strategies.
Findings show that low-cost community campaigns are feasible; however, variations in messaging, distribution strategies, and saturation levels determine whether such campaigns succeed or fail to reach priority populations.
Examining the effect of linkage disequilibrium between markers on the Type I error rate and power of nonparametric multipoint linkage analysis of two-generation and multigenerational pedigrees in the presence of missing genotype data
Hospitals admit 500 binge drinkers a dayAn epidemic of binge drinking has fuelled a dramatic increase in the number of people being hospitalised after drinking to excess, The Daily Telegraph can disclose.
The number of alcohol-related hospital admissions has increased by almost a third in just two years as 24-hour drinking laws and the greater availability of cheap alcohol lead to increased consumption.
More than 500 people a day are now being admitted to hospitals in England after drinking too much.
In some parts of the country excess drinking is the cause of almost one in 20 hospital admissions.
The figures come just two weeks after official statistics showed that nearly 13 million Britons were drinking too much because they did not appreciate the increasing strength of alcoholic drinks or the trend for larger measures.
The latest figures obtained by The Daily Telegraph are part of official data recording alcohol-related admissions to NHS hospitals in England. They show a 31 per cent rise in just two years.
. . . . . . .
____________________________________________________
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings.The past decade has seen an expansion of research and knowledge on pharmacotherapy for the treatment of alcohol dependence. The Food and Drug Administration (FDA)-approved medications naltrexone and acamprosate have shown mixed results in clinical trials.
Oral naltrexone and naltrexone depot formulations have generally demonstrated efficacy at treating alcohol dependence, but their treatment effect size is small, and more research is needed to compare the effects of different doses on drinking outcome.
Acamprosate has demonstrated efficacy for treating alcohol dependence in European trials, but with a small effect size. In U.S. trials, acamprosate has not proved to be efficacious.
Research continues to explore which types of alcohol-dependent individual would benefit the most from treatment with naltrexone or acamprosate. The combination of the two medications demonstrated efficacy for treating alcohol dependence in one European study but not in a multi-site U.S. study.
Another FDA-approved medication, disulfiram, is an aversive agent that does not diminish craving for alcohol. Disulfiram is most effective when given to those who are highly compliant or who are receiving their medication under supervision.
Of the non-approved medications, topiramate is among the most promising, with a medium effect size in clinical trials. Another promising medication, baclofen, has shown efficacy in small trials.
Serotonergic agents such as selective serotonin reuptake inhibitors and the serotonin-3 receptor antagonist, ondansetron, appear to be efficacious only among certain genetic subtypes of alcoholic.
As neuroscientific research progresses, other promising medications, as well as medication combinations, for treating alcohol dependence continue to be explored.
Computational models of ethanol-induced neurodevelopmental toxicity across species: Implications for risk assessment
GABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence.Gamma-aminobutyric acid (GABA) A receptors are believed to mediate some of the physiological and behavioral actions of ethanol. Recent studies have suggested that genetic variants of the GABA-A receptor alpha2 subunit gene (GABRA2) are associated with alcohol dependence.
The aim of this study is to confirm and extend the role of GABRA2 haplotypes in the liability to alcohol dependence.
One genetic variant was detected to significantly differ between alcohol-dependent subjects and controls. Two common 8 SNP haplotypes and their complementary alleles were identified containing this SNP and were present in 89.9% of controls and 93.4% of the alcohol-dependent individuals.
One of the haplotypes (T-C-A-C-A-T-T-C) was significantly associated with alcohol dependence and characteristics of alcohol withdrawal and severity of alcohol dependence (delirium tremens, withdrawal seizures).
These findings support and extend the three previous studies implicating a GABA-A receptor subunit as contributing to the genetic risk for alcohol dependence. Possible implications of these findings are discussed.
Read Full Abstract
News Release - Researchers Show that Fibrosis can be Stopped, Cured and ReversedDecember 27, 2007
Modified Protein Developed by UC San Diego Researchers May Lead to First Cure for Cirrhosis of the Liver
University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed. Their discovery, to be published in PLoS Online on December 26, opens the door to treating and curing conditions that lead to excessive tissue scarring such as viral hepatitis, fatty liver disease, cirrhosis, pulmonary fibrosis, scleroderma and burns.
. . . . . .
_________________________________________________________________
A Ribosomal S-6 Kinase–Mediated Signal to C/EBP-β Is Critical for the Development of Liver FibrosisIn response to liver injury, hepatic stellate cell (HSC) activation causes excessive liver fibrosis. Here we show that activation of RSK and phosphorylation of C/EBPβ on Thr217 in activated HSC is critical for the progression of liver fibrosis.
Chronic treatment with the hepatotoxin CCl4 induced severe liver fibrosis in C/EBPβ+/+ mice but not in mice expressing C/EBPβ-Ala217, a non-phosphorylatable RSK-inhibitory transgene. C/EBPβ-Ala217 was present within the death receptor complex II, with active caspase 8, and induced apoptosis of activated HSC.
The C/EBPβ-Ala217 peptides directly stimulated caspase 8 activation in a cell-free system. C/EBPβ+/+ mice with CCl4-induced severe liver fibrosis, while continuing on CCl4, were treated with a cell permeant RSK-inhibitory peptide for 4 or 8 weeks. The peptide inhibited RSK activation, stimulating apoptosis of HSC, preventing progression and inducing regression of liver fibrosis.
We found a similar activation of RSK and phosphorylation of human C/EBPβ on Thr266 (human phosphoacceptor) in activated HSC in patients with severe liver fibrosis but not in normal livers, suggesting that this pathway may also be relevant in human liver fibrosis.
These data indicate that the RSK-C/EBPβ phosphorylation pathway is critical for the development of liver fibrosis and suggest a potential therapeutic target.
Download Article (PDF)
_______________________________________________________________
The DRAM, 3(11) - Childhood Sexual Abuse, Age of First Drink, and Onset of Alcohol Dependence
But there is also another factor that gets less attention. Since the early 1990s, the federal tax on wine — $1.07 a gallon — hasn’t budged. The taxes on beer and liquor haven’t changed either, which means that, in inflation-adjusted terms, alcohol taxes have been steadily falling.
Each of the three taxes is now effectively 33 percent lower than it was in 1992. Since 1970, the federal beer tax has plummeted 63 percent. Many states taxes have also been falling.
At first blush, this sounds like good news: who likes to pay taxes, right? But taxes serve a purpose beyond merely raising general government revenue. Taxes on a given activity are also supposed to pay the costs that activity imposes on society. And for all that is wonderful about wine, beer and liquor, they clearly bring some heavy costs.
. . . . .
Mr. Cook, besides being a wine lover, has been thinking about the costs and benefits of alcohol for much of his career, and he has come up with a blunt way of describing the problem. “Do you think we should be subsidizing alcohol?” he asks. “Because that’s what we’re doing.”
. . . . And if it were somehow possible to tax only those people who were going to drive drunk in the future, it would be a wonderful idea. (Then again, we might just want to take away their driver’s licenses.) Barring clairvoyance, though, raising alcohol taxes from their current lows seems to be the fairest solution.
Mr. Cook has written a wonderful little book, “Paying the Tab,” making this case. In it, he draws on history, political philosophy and straight economics to point out that higher alcohol taxes would fit squarely in the American tradition.
. . . . .
_________________________________________________________________
News Release - Cognitive, genetic clues identified in imaging study of alcohol addictionPeople with clinical addictions know first-hand the ravages the disease can take on almost every aspect of their lives. So why do they continue addictive behaviors, even after a period of peaceable abstinence"
Some answers appear rooted in regions of the brain active during decision making.
"It's perhaps not just that people are slaves to pleasure, but that they have trouble thinking through a decision," said Charlotte Boettiger, an assistant professor of psychology at the University of North Carolina at Chapel Hill, and lead author of a study in the December issue of the Journal of Neuroscience that took a novel tack in addiction imaging research.
"Our data suggest there may be a cognitive difference in people with addictions," Boettiger said. "Their brains may not fully process the long-term consequences of their choices. They may compute information less efficiently."
The study also found that a variant of the COMT gene, which controls the level of the neurotransmitter dopamine in the cortex, was associated with a tendency to make impulsive decisions and with high activity in certain brain areas during decision making.
. . . . .
Read Full News Release
____________________________________________________________
Immediate Reward Bias in Humans: Fronto-Parietal Networks and a Role for the Catechol-O-Methyltransferase 158Val/Val Genotype
Doctors may soon offer what alcoholics need (if not what they want)
Network Support for Drinking: An Application of Multiple Groups Growth Mixture Modeling to Examine Client-Treatment Matching
Alcohol Consumption in Australia: A Snapshot, 2004-05
HIDDEN MARKOV MODELS FOR ALCOHOLISM TREATMENT TRIAL DATA
Alcohol Drinking Patterns and Prevalence of Alcohol-Abuse and Dependence in the Israel National Health Survey